Suggested Topics within your search.
Suggested Topics within your search.
- Capitalism 3
- Economic development 2
- Marxian economics 2
- Agricultural industries 1
- Agriculture 1
- Capital punishment 1
- Cognition and culture 1
- Communication 1
- Comparative economics 1
- Criminal justice, Administration of 1
- Dependency 1
- Economic aspects 1
- Educational leadership 1
- Entrepreneurship 1
- Health Policy 1
- Health promotion 1
- History 1
- Hospitality industry 1
- Human rights 1
- Labor economics 1
- Management 1
- Mass media 1
- New business enterprises 1
- Planning 1
- Poor 1
- Poverty 1
- Public Health Practice 1
- Public administration 1
- Public health 1
- School personnel management 1
-
1501
-
1502
Progress on responsive neurostimulation in treatment of drug⁃resistant epilepsy
Published 2025-01-01Get full text
Article -
1503
Immunosuppression Induced by Chronic Inflammation and the Progression to Oral Squamous Cell Carcinoma
Published 2016-01-01Get full text
Article -
1504
-
1505
-
1506
-
1507
Multicenter study for CH-VAD as a fully magnetically levitated left ventricular assist device
Published 2025-02-01Get full text
Article -
1508
-
1509
-
1510
-
1511
Prognostic Significance and Therapeutic Potential of SERPINE1 in Head and Neck Squamous Cell Carcinoma
Published 2025-01-01Get full text
Article -
1512
-
1513
A novel machine learning approach for portfolio optimization
Published 2023-09-01“…Purpose: Selection of the best stocks for the portfolio as well as allocating the optimal amount of capital per stock in the portfolio are serious challenges in investing in the stock market. …”
Get full text
Article -
1514
-
1515
Inosine enhances the efficacy of immune‐checkpoint inhibitors in advanced solid tumors: A randomized, controlled, Phase 2 study
Published 2024-09-01“…Methods This single‐center, prospective, randomized, open‐label study was conducted, from January 2021 to December 2022, in Beijing Friendship Hospital, Capital Medical University, and participants were randomly assigned (1:1) to either the inosine (trial) or non‐inosine (control) group that received inosine (dosage: 0.2 g, three times/day) + PD‐1/PD‐L1 inhibitor or only PD‐1/PD‐L1 inhibitor ± targeted ± chemotherapy, respectively. …”
Get full text
Article -
1516
-
1517
-
1518
Genetic Predisposition and Salt Sensitivity in a Chinese Han Population: The EpiSS Study
Published 2020-01-01Get full text
Article -
1519
-
1520